SOLCO Trademark

Trademark Overview


On Thursday, November 17, 2022, a trademark application was filed for SOLCO with the United States Patent and Trademark Office. The USPTO has given the SOLCO trademark a serial number of 97681398. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2024. This trademark is owned by Prinston Pharmaceutical Inc.. The SOLCO trademark is filed in the Pharmaceutical Products category with the following description:

Analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; antimicrobial preservatives for cosmetics and pharmaceuticals; pharmaceutical astringents being astringents for medical purposes; balms for pharmaceutical purposes; cream of tartar for pharmaceutical purposes; creosote for pharmaceutical purposes; dermatological pharmaceutical products; digestives for pharmaceutical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ferments for pharmaceutical purposes; inhaled pharma...
solco

General Information


Serial Number97681398
Word MarkSOLCO
Filing DateThursday, November 17, 2022
Status700 - REGISTERED
Status DateTuesday, March 26, 2024
Registration Number7335535
Registration DateTuesday, March 26, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Goods and ServicesAnalgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; antimicrobial preservatives for cosmetics and pharmaceuticals; pharmaceutical astringents being astringents for medical purposes; balms for pharmaceutical purposes; cream of tartar for pharmaceutical purposes; creosote for pharmaceutical purposes; dermatological pharmaceutical products; digestives for pharmaceutical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ferments for pharmaceutical purposes; inhaled pharmaceutical preparations for the treatment of respiratory disease; injectable pharmaceuticals for treatment of anaphylactic reactions; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; iodine for pharmaceutical purposes; liquorice for pharmaceutical purposes; menthol for pharmaceutical purposes; pharmaceutical antitussive-cold preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating hypertension; pharmaceutical products for treating respiratory disease and asthma; pharmaceutical products for the treatment of joint disease; plant extracts for medical, veterinary and pharmaceutical purposes; potassium preparations for pharmaceutical purposes; pharmaceutical preparations and substances for weight loss; vitamin and mineral supplements for use as ingredients in the food and pharmaceutical industry; drug delivery agents in the form of coatings for pills for facilitating the delivery of a wide range of pharmaceuticals; biological preparations for the treatment of cancer and autoimmune deficiencies and disorders; pharmaceutical, veterinary and sanitary preparations, namely, conjugates of organic and inorganic chemicals with polypeptides, proteins, artificial polypeptides, artificial proteins produced by genetic engineering and for the treatment of viral and infectious diseases, immune system disorders, cancer, diabetes, cardiovascular diseases, central nervous system disorders and diseases; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateThursday, December 8, 2022
Primary Code005
First Use Anywhere DateWednesday, June 3, 2009
First Use In Commerce DateWednesday, June 3, 2009

Trademark Owner History


Party NamePrinston Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Party NamePrinston Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Party NamePrinston Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Trademark Events


Event DateEvent Description
Tuesday, March 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 7, 2023NON-FINAL ACTION E-MAILED
Thursday, September 7, 2023NON-FINAL ACTION WRITTEN
Wednesday, August 30, 2023ASSIGNED TO EXAMINER
Thursday, December 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 21, 2022NEW APPLICATION ENTERED